medigraphic.com
ISSN 1561-2996 (Electronic)
ISSN 0864-0289 (Print)

2020, Number 3

<< Back Next >>

Rev Cubana Hematol Inmunol Hemoter 2020; 36 (3)

Sideroblastic anemia, a rare disease of multiple causes

Martínez-Sánchez LM, Castañeda PS

Language: Spanish
References: 26
Page:
PDF size: 378.69 Kb.


ABSTRACT

Introduction: Sideroblastic anemia is a hematological disorder that alters the hematopoiesis process. This condition affects, to a great extent, the erythroid line. In addition, alterations occur in the synthesis of the heme group due to mitochondrial dysfunction in the bone marrow cells.
Objective: To investigate sideroblastic anemia, its variables and the different types of presentation of this disease.
Methods: A literature review was carried out in the MEDLINE, EMBASE, Lilacs and ScienceDirect databases, using the descriptors anemia sideroblástica [sideroblastic anemia], hematopoyesis [hematopoiesis], anomalías congénitas [congenital anomalies] and 5-aminolevulinato sintetasa [5-aminolevulinate synthetase], in Spanish and English. Twety-six articles related to the topic were selected. An analysis and summary of the revised bibliography was carried out.
Information analysis and synthesis: It is a disease of congenital origin or secondary to other processes such as alcohol consumption or induced by some medications. It occurs infrequently and its diagnosis is mostly made through laboratory studies, such as peripheral blood smear and bone marrow study, to which various stains can be applied, as well as sequencing or even polymerase chain reaction.
Conclusion: Sideroblastic anemia is a disease that can be related to other hematological alterations that modify iron metabolism. The curative treatment is the transfusion of blood components. An individualized approach should be used according to the type of sideroblastic anemia.


REFERENCES

  1. Tesarova M, Vondrackova A, Stufkova H, Veprekova L, Stranecky V, Berankova K, et al. Sideroblastic anemia associated with multisystem mitochondrial disorders. Pediatr Blood Cancer. 2018;66(4):1-8.

  2. Ducamp S, Fleming MD. The molecular genetics of sideroblastic anemia. Blood. 2019;133(1):59-69

  3. Ahmad KN, Kamran S, Sarfraz T, Bangash KA, Bano A, Bano F. Sideroblastic anemia-a hitherto unrecognized cause of unexplained anemia. Pak Armed Forces Med J. 2018;68(6):1755-60.

  4. Thierry Alcindor, Kenneth R. Bridges. Sideroblastic anemias. Br. J. Haematol. 2002;116:733-43.

  5. Lewis G, Wise MP, Poynton C, Godkin A. A case of persistent anemia and alcohol abuse. Nat. Rev Gastroenterol. Hepatol. 2007;4(9):521-6.

  6. Tenner S, Rollhauser C, Butt F, Gonzales P. Sideroblastic anemia a diagnosis to consider in alcoholic patients. Postgrad Med J. 1992;92(7):147-9.

  7. Fujiwara T, Harigae H. Molecular pathophysiology and genetic mutations in congenital sideroblastic anemia. Free Radic. Biol. Med. 2019; 133: 179-85.

  8. Kenneth R, Alcindor T. Sideroblastic anemias. Br. J. Haematol. 2002;116:733-43.

  9. Susanto TAK, Bhattacharyya R. X-linked Sideroblastic Anemia in a Malay Boy With ALAS2 S568G Mutation. J Pediatr Hematol Oncol. 2017;39(5):408-09. doi: 10.1097/MPH.0000000000000814

  10. Yu HJ, Lee YJ, Shim JW, Kim DS, Shim JY, Park MS, et al. Mutation Analysis of X-linked Sideroblastic Anemia in a 12-Month-Old Boy by Massively Parallel Sequencing. Ann Lab Med. 2018;38(4):389-92. doi:10.3343/alm.2018.38.4.389

  11. Imataki O, Uchida S, Uemura M, Kadowaki N. Graft failure after reduced-intensity stem cell transplantation of congenital sideroblastic anemia. Pediatr. Hematol. Oncol. 2019;36(1):46-51.

  12. Creasey T, Biss T, Lambert J, Smith F, Clark B, Carey P. Pyridoxine-sensitive X-linked 'sideroblastic' anaemia in the absence of ring sideroblasts - molecular diagnosis. Br J Haematol. 2018;180(1):10. doi: 10.1111/bjh.14909

  13. Long Z, Li H, Du Y, Han B. Congenital sideroblastic anemia: advances in fene mutations and pathophysiology. Gene. 2018;668:182-9

  14. Cotter PD, May A, Fitzsimons EJ, Houston T, Woodcock BE, Sabah AI, et al. Late-onset X-linked sideroblastic anemia. Missense mutations in the erythroid delta-aminolevulinate synthase (ALAS2) gene in two pyridoxine-responsive patients initially diagnosed with acquired refractory anemia and ringed sideroblasts. J Clin Invest. 1995;96(4):2090-6. doi:10.1172/JCI118258

  15. Cox TC, Bottomley SS, Wiley JS, Bawden MJ, Matthews CS, May BK. X-linked pyridoxine-responsive sideroblastic anemia due to a Thr 388-to-Ser substitution in erythroid 5-aminolevulinate synthase. N Engl J Med. 1994;330(10):675-9. doi:10.1056/NEJM199403103301004

  16. Protasova M, Grigorenko A, Tyazhelova T, Andreeva T, Reshetov D, Gusev F, et al. Whole-genome sequencing identifies a novel ABCB7 gene mutation for X-linked congenital cerebellar ataxia in a large family of Mongolian ancestry. Eur J Hum. Genet. 2016;24:550-5.

  17. Dussiau C, Fontenay M. Mechanisms underlying the heterogeneity of myelodysplastic syndromes. Exp Hematol. 2018;58:17-26.

  18. Malcovati L, Cazzola M. Recent advances in the understanding of myelodysplastic syndromes with ring sideroblasts. Br J Haematol. 2016;174:847-58.

  19. An W, Zhang J, Chang L, Zhang Y, Wan Y, Ren Y, et al. Mutation analysis of Chinese sporadic congenital sideroblastic anemia by targeted capture sequencing. J Hematol Oncol. 2015;8:55. doi:10.1186/s13045-015-0154-0

  20. Visconte V, Tabarroki A, Hasrouni E, Maciejewski JP, Hsi ED, Tiu RV, et al. Molecular and phenotypic heterogeneity of refractory anemia with ring sideroblasts associated with marked thrombocytosis. Leuk Lymphoma. 2016;57(1):212-5. doi: 10.3109/10428194.2015.1045895

  21. Berilla E, Breydo L, Gouya L, Puy H, Uversky V, Ferreira G. Isoniazid inhibits human erythroid 5-aminolevulinate synthase: Molecular mechanism and tolerance study with four X-linked protoporphyria patients. Biochim Biophys Acta. 2017;1863:428-39.

  22. Bottomley S, Fleming M. Sideroblastic anemia: diagnosis and management. Hematol Oncol Clin N Am. 2014;28(4):653-70.

  23. Cazzola M, Malcovati L. Diagnosis and treatment of sideroblastic anemias: from defective heme synthesis to abnormal RNA splicing. Hematology Am Soc Hematol Educ Program. 2015;2015:19-25. doi: 10.1182/asheducation-2015.1.19.

  24. Rovó A, Stüssi G, Meyer-Monard S, Favre G, Tsakiris D, Heim D et al. Sideroblastic changes of the bone marrow can be predicted by the erythrogram of peripheral blood. Int J Lab Hematol. 2010;32(3):329-35. doi:10.1111/j.1751-553X.2009.01185.x

  25. Li P, Shahmarvand N, Lynch D, Gotlib JR, Merker JD, Zehnder JL, et al. Revisiting diagnostic criteria for myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis: Borderline cases without anemia exist. Int J Lab Hematol. 2019;41(3):345-52. doi: 10.1111/ijlh.12981

  26. Patnaik MM, Tefferi A. Refractory anemia with ring sideroblasts (RARS) and RARS with thrombocytosis: "2019 Update on Diagnosis, Risk-stratification, and Management". Am J Hematol. 2019;94(4):475-88. doi: 10.1002/ajh.25397




2020     |     www.medigraphic.com